The proposal would make menopause treatments affordable and accessible under the following components:

Component 1: Provide $50 million annually to make menopause treatments more affordable and accessible. This Commonwealth funding should go towards:

• Subsidising TGA approved menopausal hormone therapy (MHT).
• Purchasing more doses of MHT and making them more accessible across Australia.
• Purchasing alternative forms of MHT medications.

Component 2:

The proposal would make menopause treatments affordable and accessible under the following components:

Component 1: Provide $50 million annually to make menopause treatments more affordable and accessible. This Commonwealth funding should go towards:

• Subsidising TGA approved menopausal hormone therapy (MHT).
• Purchasing more doses of MHT and making them more accessible across Australia.
• Purchasing alternative forms of MHT medications.

Component 2:

The proposal would make menopause treatments affordable and accessible under the following components:

Component 1: Provide $50 million annually to make menopause treatments more affordable and accessible. This Commonwealth funding should go towards:

• Subsidising TGA approved menopausal hormone therapy (MHT).
• Purchasing more doses of MHT and making them more accessible across Australia.
• Purchasing alternative forms of MHT medications.

Component 2:

The proposal would provide $5 million over 4 years to deliver a national education campaign on menopause and perimenopause.

This would focus on educating GPs through an accredited training program, to ensure they are well-equipped to support their patients, as well as raising public awareness about menopause symptoms and treatment options to reduce stigma and encourage open conversations.

The proposal would be non-ongoing, distribute funding evenly over 4 years, and start from 1 July 2026.

The proposal would provide $5 million over 4 years to deliver a national education campaign on menopause and perimenopause.

This would focus on educating GPs through an accredited training program, to ensure they are well-equipped to support their patients, as well as raising public awareness about menopause symptoms and treatment options to reduce stigma and encourage open conversations.

The proposal would be non-ongoing, distribute funding evenly over 4 years, and start from 1 July 2026.

The proposal would provide $5 million over 4 years to deliver a national education campaign on menopause and perimenopause.

This would focus on educating GPs through an accredited training program, to ensure they are well-equipped to support their patients, as well as raising public awareness about menopause symptoms and treatment options to reduce stigma and encourage open conversations.

The proposal would be non-ongoing, distribute funding evenly over 4 years, and start from 1 July 2026.

The proposal would provide $5 million over 4 years to deliver a national education campaign on menopause and perimenopause.

This would focus on educating GPs through an accredited training program, to ensure they are well-equipped to support their patients, as well as raising public awareness about menopause symptoms and treatment options to reduce stigma and encourage open conversations.

The proposal would be non-ongoing, distribute funding evenly over 4 years, and start from 1 July 2026.